Literature DB >> 31352362

Viruses and non-allergen environmental triggers in asthma.

Florence Chau-Etchepare1, Joshua L Hoerger2, Brooks T Kuhn1, Amir A Zeki1,3, Angela Haczku1,3, Samuel Louie1, Nicholas J Kenyon1,3, Cristina E Davis4, Michael Schivo1,3.   

Abstract

Asthma is a complex inflammatory disease with many triggers. The best understood asthma inflammatory pathways involve signals characterized by peripheral eosinophilia and elevated immunoglobulin E levels (called T2-high or allergic asthma), though other asthma phenotypes exist (eg, T2-low or non-allergic asthma, eosinophilic or neutrophilic-predominant). Common triggers that lead to poor asthma control and exacerbations include respiratory viruses, aeroallergens, house dust, molds, and other organic and inorganic substances. Increasingly recognized non-allergen triggers include tobacco smoke, small particulate matter (eg, PM2.5), and volatile organic compounds. The interaction between respiratory viruses and non-allergen asthma triggers is not well understood, though it is likely a connection exists which may lead to asthma development and/or exacerbations. In this paper we describe common respiratory viruses and non-allergen triggers associated with asthma. In addition, we aim to show the possible interactions, and potential synergy, between viruses and non-allergen triggers. Finally, we introduce a new clinical approach that collects exhaled breath condensates to identify metabolomics associated with viruses and non-allergen triggers that may promote the early management of asthma symptoms. © American Federation for Medical Research 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  asthma; tobacco

Year:  2019        PMID: 31352362     DOI: 10.1136/jim-2019-001000

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  11 in total

Review 1.  Trained immunity in type 2 immune responses.

Authors:  Franziska Hartung; Julia Esser-von Bieren
Journal:  Mucosal Immunol       Date:  2022-09-05       Impact factor: 8.701

Review 2.  Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling.

Authors:  Grzegorz Kardas; Piotr Kuna; Michał Panek
Journal:  Front Immunol       Date:  2020-06-18       Impact factor: 7.561

Review 3.  Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma.

Authors:  Chioma Enweasor; Cameron H Flayer; Angela Haczku
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

4.  Pediatric Asthma Exacerbation in Children with Suspected and Confirmed Coronavirus Disease 2019 (COVID-19): An Observational Study from Saudi Arabia.

Authors:  Ali Alsuheel Asseri
Journal:  J Asthma Allergy       Date:  2021-09-23

5.  Different effects of smoking on atopic and non-atopic adult-onset asthma.

Authors:  Taina K Lajunen; Jouni J K Jaakkola; Maritta S Jaakkola
Journal:  Clin Transl Allergy       Date:  2021-10-11       Impact factor: 5.871

Review 6.  Insights Into Type I and III Interferons in Asthma and Exacerbations.

Authors:  Helen E Rich; Danielle Antos; Natalie R Melton; John F Alcorn; Michelle L Manni
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 7.  Virome in the Lungs: The Role of Anelloviruses in Childhood Respiratory Diseases.

Authors:  Giulia Dodi; Marina Attanasi; Paola Di Filippo; Sabrina Di Pillo; Francesco Chiarelli
Journal:  Microorganisms       Date:  2021-06-23

Review 8.  Microbiome Research and Multi-Omics Integration for Personalized Medicine in Asthma.

Authors:  Marianthi Logotheti; Panagiotis Agioutantis; Paraskevi Katsaounou; Heleni Loutrari
Journal:  J Pers Med       Date:  2021-12-05

9.  The Association between the Occurrence of Asthma and Antecedents of Exposure to Environmental Tobacco Smoke in the Previous Year in Children: An Incidence-Density Study.

Authors:  Hayat Bentouhami; Lidia Casas; Joost Weyler
Journal:  Int J Environ Res Public Health       Date:  2022-03-02       Impact factor: 3.390

10.  Investigation of the Mechanisms of Chuankezhi Injection in the Treatment of Asthma Based on the Network Pharmacology Approach.

Authors:  Hao Zhu; Yuhuan Shi; Shanshan Jiang; Xiuxiu Jiao; Hui Zhu; Rong Wang; Yongfang Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.